GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Galenica Ltd. (XSWX:GALE) » Definitions » 3-Year EPS without NRI Growth Rate

Galenica (XSWX:GALE) 3-Year EPS without NRI Growth Rate : -3.60% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Galenica 3-Year EPS without NRI Growth Rate?

Galenica's EPS without NRI for the six months ended in Dec. 2023 was CHF1.82.

During the past 12 months, Galenica's average EPS without NRI Growth Rate was 0.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -3.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Galenica was 22.90% per year. The lowest was -3.60% per year. And the median was 11.70% per year.


Competitive Comparison of Galenica's 3-Year EPS without NRI Growth Rate

For the Medical Distribution subindustry, Galenica's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galenica's 3-Year EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Galenica's 3-Year EPS without NRI Growth Rate falls into.



Galenica 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Galenica  (XSWX:GALE) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Galenica 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Galenica's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Galenica (XSWX:GALE) Business Description

Industry
Traded in Other Exchanges
Address
Untermattweg 8, Bern, CHE, 3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is primarily operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.

Galenica (XSWX:GALE) Headlines

No Headlines